Event Calendar

Previous month Previous day Next day Next month
By Year By Month By Week Today Search Jump to month

 

Facing IPF Together: A Case-Based Team Approach | Columbia University      
Saturday, November 05, 2016 8:30 – 1:00      

Facing IPF Together: A Case-Based Team Approach
Connecting the Multidisciplinary Care Team and Patients

Saturday, November 5, 2016 
8:30 AM–1:00 PM
Columbia University Medical Center
Bard Hall
50 Haven Avenue
New York, NY

Register

Hosted by Columbia University Medical Center

Jointly provided by The France Foundation and the Pulmonary Fibrosis Foundation

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.


AGENDA    
8:30 AM   Registration and Breakfast
9:15 AM   Diagnosis and Treatment with Case Review
11:00 AM   The Patient Journey
11:15 AM   What’s on the Horizon: Potential Therapies in Clinical Trials
11:30 AM   Breakout Sessions
  • Problem Based Learning Cases for Clinicians
  • Patient/Caregiver Workshop
1:00 PM   Adjourn


FACULTY

Nina Patel, MD (Chair)
Assistant Professor of Clinical Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Co-Director of the ILD Program
Columbia University Medical Center
New York, NY

David Lederer, MD, MS (PILOT Co-Chair)
Herbert Irving Assistant Professor of Medicine and Epidemiology (in Pediatrics)
Associate Medical Director, Lung Transplant Program
Co-Director, Interstitial Lung Disease Program
Columbia University Medical Center/New York Presbyterian Hospital
New York, NY

Robert Kaner, MD
Associate Professor of Clinical Medicine and Genetic Medicine
Weill Cornell Medicine
Associate Attending Physician
Pulmonary Disease Medicine and Internal Medicine
New York Presbyterian Weill Cornell Medical Center
New York, NY

Anna Rozenshtein, MD
Associate Professor of Radiology
Affiliated Faculty
Columbia University
New York, NY

Target Audience: This activity is intended for pulmonologists, critical care specialists, thoracic radiologists, pathologists, fellows, nurse practitioners, physician assistants, and other health care providers who manage patients with IPF. It is also intended for patients and caregivers.

Statement of Need: The diagnosis of IPF is difficult and requires multiple findings from several specialists. Awareness of guidelines and the criteria for diagnosis is incomplete for many pulmonologists and radiologists. Furthermore, pulmonologists underestimate the clinical impact of available treatments and have difficulty communicating the therapeutic impact of these agents on disease progression to patients. Clinical evidence guiding treatment decisions such as choice of therapy, combination therapy, and switching therapy is incomplete, requiring detailed discussions between patients and providers.

Educational Activity Learning Objectives 
Upon completion of this course, the participants should be able to:

  • Apply current ATS/ERS criteria to the process for differentially diagnosing IPF.
  • Integrate histopathologic with high-resolution computed tomography (HRCT) data in the diagnosis of IPF when necessary.
  • Explain disease progression and the heterogeneity of the disease.
  • Examine emerging research related to IPF treatment.
  • Select appropriate therapies that reflect current evidence and/or widely accepted guidelines that are individualized to patients.
  • Utilize dose modification to manage side effects in patients.
  • Recognize treatment success, disease progression, and when/if to switch therapy.
  • Collaborate with patients and/or caregivers in overcoming barriers to daily living.


Accreditation/Designation Statements:
 This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The France Foundation and the Pulmonary Fibrosis Foundation. The France Foundation is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation 
Physicians:
 The France Foundation designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy: In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Disclosure of Unlabeled Use: TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Media Disclosure: Your registration, attendance at, and/or participation in this meeting constitutes consent to being photographed, videotaped, or recorded during the meeting by The France Foundation, its educational collaborators, or anyone authorized on behalf of these organizations. You further authorize, without any compensation paid to you, the use of any photographs, videos, or recordings that contain your likeness, image, or voice in any educational, informational, commercial, or promotional materials produced and/or distributed by The France Foundation, its educational collaborators, or anyone authorized by these organizations, as well as on any Internet sites maintained by any of these entities. Images/recordings used for these purposes will not be sold, and no personal information about you or the subject (other than event location and date) will be included in the production of any material.

The France Foundation fully complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant of this activity given by The France Foundation is in need of accommodation, please submit written requests via fax to 860-434-5390.

 

 

Event Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.


Venue Information:
Location:
Columbia University Medical Center
Street: 50 Haven Avenue
City: New York
State: NY

ISO Start Time: 2016-11-05T08:30:00

 

Access other Therapeutic Areas: